Delivery Order HHSO100201600004I-75A50120F33013

This is a delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this $8,609,815.00 firm-fixed-price contract modification is to fund Option Year 2 for the production of a CGMP (Current Good Manufacturing Practice) adjuvant at the clinical or commercial scale. The overall contract is part of the Pandemic...

<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a Definitive Contract valued at $7,837,399,999.00 to Moderna US, Inc. Moderna US Inc. Division for COVID-19 MRNA Vaccines. The place of performance will be in Cambridge, MA 02139, USA and the period of performance is from July 28, 2022 through March 31, 2023. The pricing structure is Firm Fixed Price.</p>

This is a $2,100,000.00 firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Medimmune LLC for the funding of CGMP influenza vaccine optimized master and working seed lot production. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 contract vehicle. There is no set-aside designation for this award. The contract has an ultimate completion date of October 31, 2013.

<p>This is a $205,003,103.62 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Modex Therapeutics, Inc. to advance the development of potent, cross-reactive multispecific antibodies for the preparedness countermeasure of COVID-19 and seasonal and highly pathogenic avian influenza. The contract has an ultimate completion date of January 18, 2030. This award is not a set-aside contract.</p>

This is a $65,806,649.98 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Biofactura Inc. for preclinical and manufacturing development activities. The contract includes cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract was awarded on September 26, 2019 with an ultimate completion date of March 30, 2029. The contract has no...

This is a definitive contract awarded by the Joint Program Executive Office for Chemical and Biological Defense, a Defense Department agency, to Moderna, Inc. for 100 million doses of the SARS-CoV-2 mRNA-1273 vaccine. The $8.2 billion firm fixed price contract has an ultimate completion date of August 10, 2023. Moderna, a manufacturer of pharmaceutical goods, has previously received prime and subcontract awards from various government agencies including the Department of Veterans Affairs,...

This is a delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract, valued at $8,782,011.00, is for the provision of CGMP (Current Good Manufacturing Practice) adjuvant at the clinical or commercial scale. The contract is a firm-fixed-price delivery order with a period of performance through December 12, 2025. The contract does not have a...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Battelle Memorial Institute, doing business as Battelle, for $3,977,119. The objective is to explore immune correlates of protection in rhesus macaques administered various SARS-CoV-2 vaccine candidates designed by Moderna, Novavax, Janssen and Sanofi Pasteur. Battelle will conduct the study under an approved quality management plan...

<p>This is a firm fixed-price delivery order awarded to Glaxosmithkline, LLC by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, under IDIQ contract 75A50122D00002. The purpose is to procure services for storage and stability of vaccine bulk lots for the U.S. Department of Defense during the third year of the base period. The award ceiling is $312,168.64 and the ultimate completion date is May 21, 2027. The contract has no set-aside designation.</p>

This is a delivery order issued under IDIQ contract #75A50122D00002 to Glaxosmithkline, LLC, a pharmaceutical company, to establish fill/finish activities for the COVID-19 vaccine adjuvant AS03 to support the COVID-19 federal response. The $15,411,200 firm fixed price task order was awarded on February 27, 2024 by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the Department of Health and Human Services. The contract has an ultimate completion...